Skip to main content

Animations

MJFF Publications

7321 - 7330 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2022
  • 2018
  • 2025
  • 2022
  • 2019
  • 2025
  • 2017
  • 2018
  • 2021
  • Summary Details
    OPEN
    Title: CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adu0726
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28934
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27385
    Citation Count: 37
  • Summary Details
    OPEN
    Title: High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.70367
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01318-7
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Discovery of Volatile Biomarkers of Parkinson’s Disease from Sebum
    Journal Name: ACS Central Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acscentsci.8b00879
    Citation Count: 146
  • Summary Details
    RESTRICTED
    Title: Characteristics of hospitalized patients with restless legs syndrome in Hawaiʻi by race/ethnicity
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108038
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.07.007
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Optical Structural Analysis of Individual α‐Synuclein Oligomers
    Journal Name: Angewandte Chemie International Edition
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/anie.201710779
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Validating Differential Volatilome Profiles in Parkinson’s Disease
    Journal Name: ACS Central Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acscentsci.0c01028
    Citation Count: 36
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.